PROGRAMM JAHRESTAGUNG 2012 30. Nov. – 2. Dez ... - ÖGDV

Posterübersicht
P 35 Long-term improvement in patient-reported outcomes after transition
from methotrexate to ustekinumab in moderate to severe psoriasis:
TRANSIT Week 52 results
K. Reich, L. Puig, T. Luger, J. Lambert, S. Chimenti, G. Girolomoni, J.-F. Nicolas,
K. Kragballe, S. Mistry, P. Bergmans, G. Thompson, J. Barker, C. Paul (Hamburg,
Barcelona, Munster, Ghent, Rome, Verona, Lyon, Arhus, High Wycombe, Tilburg,
London, Toulouse)
P 36 Anti-IL23p19 (MK-3222): effects on the hallmarks of inflammation
in psoriasis
Christine Bangert, Daniela Laimer, Elisabeth Riedl, Baerbel Reininger,
Elli Greisenegger, Ann Horowitz, Danlin Xu, Matias Morrison, Georg Stingl,
Tamara Kopp (Wien)
P 37 MK-3222, an anti-IL23p19 antibody, is safe and effective in the treatment
of psoriasis
Tamara Kopp, Elisabeth Riedl, Christine Bangert, Eli Greisenegger, Ann Horowitz,
Thomas Marbury, Robert Stonerock, Victor Vidals, Jonathan Dosik, Claus Zachariae,
Norbert Reider, Alan J Kivitz, Danlin Xu, Xiaoli Shirley Hou, A.S. Zandvliet,
Matias Morrison, Suzanne Khalilieh (Wien, Whitehouse Station, Orlando, Lenexa,
Paramus, Copenhagen, Innsbruck, Duncansville)
P 38 Telepsor - Teledermatologie, mobile Betreuung von Psoriasispatienten/patientinnen
bei einer Therapie mit Ustekinumab -eine 'Nicht-interventionelle
Studie'
Martin Inzinger, Regina Fink-Puches, Barbara Fleischanderl,
Verena Ahlgrimm-Siess, Simon Pucher, Wolfgang Weger, Wolfgang Salmhofer,
Rainer Hofmann-Wellenhof (Graz, Wels, Salzburg)
P 39 Subunguales Verrukoeses Spinozellulaeres Karzinom der Grosszehe
Tobias Thuile, Lukas Tappeiner, Ulrike Prugg, Jenny Deluca, Klaus Eisendle
(Bolzano)
P 40 Targeting KRT17 by peptide aptamers as a rational drug design strategy
for future BCC treatment
Johann Bauer, Raphaela Rid, Julia Herzog, Helmut Hintner, Kamil Oender
(Salzburg)
P 41 Merkel cell carcinoma (MCC): mitoses, lymphovascular invasion,
expression of Ki 67 and bcl-2 correlate with disease progression
Babak Monshi, Michael Marker, Daniela Muehlehner, Andreas Steiner,
Klemens Rappersberger (Wien)
P 42 Pre-therapeutic laboratory findings, extent of metastasis and choice of
treatment as prognostic markers in ocular melanoma - a single center
experience
Nikolaus Schicher, Gundula Edelhauser, Kaan Harmankaya, Katja Schindler,
Andreas Gleiss, Hubert Pehamberger, Christoph Höller (Wien)
37